BCHI
10/17/26

GMO Beyond China ETF (BCHI)

Saturday
7:43 AM
ThesisThe ETF is benefiting from increased investor interest in emerging markets outside of China, driven by favorable economic conditions and policy reforms.

What’s Driving the Stock

  1. 01Emerging markets outside of China have seen a 15% increase in foreign direct investment (FDI) year-to-date, indicating strong investor confidence.
  2. 02The ETF's recent rebalancing has increased exposure to high-growth sectors like renewable energy, which are projected to grow at 25% CAGR over the next five years.
  3. 03Recent policy shifts in India promoting foreign investment could lead to a 10% increase in AUM over the next 12 months.
  4. 04Increased urbanization rates in Southeast Asia are expected to drive consumer spending growth by 20% over the next three years.
  5. 05Sustainable investing in emerging markets
  6. 06Digital transformation in Southeast Asia
  7. 07Performance of Asian markets outside of China, particularly India and Southeast Asia
  8. 08Changes in investor sentiment towards emerging market equities
Latest Snapshot
1Y Return
+32.7%

BCHI Chart

21.924.226.428.630.926.72BCHI Daily26.72Mar '26May '26Jul '26Aug '26

My Notes

  • "Investors are increasingly looking beyond China for growth opportunities in Asia."
  • Moat: The ETF's focus on non-Chinese markets provides a unique positioning that differentiates it from competitors heavily weighted in China.
  • growth - Investors seeking exposure to high-growth markets outside of China are likely to be attracted to this ETF.
  • Rising interest rates can lead to increased borrowing costs and may dampen consumer spending in emerging markets…
  • Watch on earnings: AUM growth rate, Performance relative to MSCI Emerging Markets Index, Investor inflows/outflows.

One Sentence Summary:

GMO Beyond China ETF: the setup is constructive — emerging markets outside of china have seen a 15% increase in foreign direct investment (fdi) year-to-date.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.